Compier PSMF

Home / Innovation / Compier PSMF

Establish an Audit-ready Digital PSMF with improvised Process Efficiency and Regulatory Compliance 

The PSMF (the blueprint of your global Pharmacovigilance process) is mandatorily requested and assessed by any national competent authorities or by the Agency during regulatory inspections and audits. From time to time, It is mandatory for any MAH (Manufacturing Authorization Holder) to update all Core elements of PSMF along with all the information in the Annexures (A to I).

Today, your EU QPPV, drug safety team members, safety officers at global sites along with outsourcing team members rely on a manual collection of PSMF relevant information/ updates from various siloed data sources and team members located across the globe. The team further spend time on numerous meeting/ conference calls and share information via emails, shared folders etc. Further, the core document and annexures are managed through MS word documents and spreadsheets. This entire process of PSMF life cycle management is redundant and inefficient.

How Compier ePSMF Can Help

Compier ePSMF enables pharma companies to digitalize and automate the complete PSMF life cycle management helping them to get audit-ready and stay compliant with FDA, EU and other global regulations. Compier ePSMF facilitates the digitally authoring and update of core and annexure documents.

It automatically updates data points in the annexures obtained from other Compier modules and through source system integrations. The default ePSMF templates enables clients to quickly adopt this capability in their current process.

Business Plan

Key Solution Capabilities

  • Modular and Templatized: Manage ePSMF components as modules and templates
  • Digital Authoring: Author within application without any dependency on third party apps
  • Collaborative Review: Review modules of ePSMF with multiple reviewers at the same time
  • Workflow driven activities: Configurable workflow from authoring till expiry
  • Access Control: Define controls to who can view, or edit ePSMF
  • Version Controlled: Access latest version of ePSMF with archived older versions
  • Auto Update Rules: Auto update modules, templates and ePSMF based on rules defined
  • Sharing: Share ePSMF in various formats PDF, ppt, through various channels
  • Alerts & Notifications: Get alerted and notified on work assignment, expiry and changes
  • Insights & Analytics: Ready to use and extendable dash boards, performance indicators
  • Audit-Ready:  Facilitate remote audits by providing ePSMF online access to auditors from any part of the world.

Seamless Integrations with various source systems to enable 100% process automation

  • Drug Safety Database
  • Signal Management System
  • Clinical Systems
  • Quality Management System
  • Training Management System
  • Other modules of Compier
  • Other organization wide operational data source systems
Meeting
Techsol Regulatory Compliance

Key Advantages

  • Gain process efficiency with a modern and purpose-built solution
  • Improve oversight and reduce risk with alerts and notifications
  • Stay current, take advantage of best practices and ready to use modular, version-controlled templates
  • Seamlessly collaborate with global team members by digitally authoring core document and flexible workflow for end to end management
  • Modern architecture, advanced functionalities, and ready built-in connectors for various standard third-party databases for an efficient process
  • Real-time reports and dashboards provide the necessary visibility for risk mitigation and compliance

How Do we Deliver

ePSMF is a component of our Compier platform. It can be deployed on its own or in combination with other modules of the platform.

Our comprehensive technology platform, process accelerators and subject matter expertise enable you with a comprehensive solution to digitalize and automate the entire compliance associated with PSMF. Our solutions are flexible, modular and can be deployed by MAH, QPPV office and CRO companies globally or at local entities.

New Insights

4 Effective Strategies to Accelerate Site Selection to Activation

Introduction to the site selection process Clinical research organizations (CRO) predominantly rely on the internal networks and investigator database to support a clinical study for a drug. As the clinical sphere continues to expand at a rapid pace, there is an upsurge in demand for clinical trial sites worldwide. CROs are striving for new sites […]

Aggregate Reporting – Significance, Classification and Challenges

Aggregate reports are the cumulative reports in the database that emphasise on evaluation of safety profile and risk-benefit analysis of a drug. Aggregate reporting is the process of compilation and submission of aggregate reports to the regulatory agencies over the period of the product’s life cycle (during pre-marketing and post-marketing phase) to provide a comprehensive [...]

Literature Screening – Process overview, challenges en-route and the scope for automation

Medical and scientific literature is a valuable source of safety information that helps in monitoring benefit-risk profiles and emerging safety issues of medicinal products. Literature screening is conducted to ascertain abstracts and articles that provide crucial information on serious and non-serious Individual Case Safety Reports (ICSR) reports and risk-benefit assessment of a drug. The scientific […]

Get in Touch with Us